Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
59.05
+0.45 (0.77%)
Aug 7, 2026, 1:03 PM CET
BME:ROVI Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 773.05 | 743.48 | 763.75 | 829.51 | 817.7 | 648.68 |
Revenue Growth | 3.21% | -2.65% | -7.93% | 1.44% | 26.06% | 54.46% |
Gross Profit Gross Profit Growth | 615.62 | 482.03 | 477.7 | 488.42 | 516.76 | 384.82 |
Operating Income Operating Income Growth | 134.84 | 185.84 | 179.4 | 220.13 | 255.85 | 181.57 |
Net Income Net Income Growth | 185.18 | 140.44 | 136.88 | 170.34 | 199.67 | 153.08 |
Earnings Per Share EPS Growth | 3.62 | 2.75 | 2.67 | 3.20 | 3.73 | 2.76 |
EPS Growth | 40.02% | 3.00% | -16.56% | -14.21% | 35.14% | 150.91% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Manufacturing Manufacturing Growth | 513.22 | 494.13 | 600.35 | 644.41 | 619.23 | 471.79 |
Other Other Growth | 0.14 | 0.1 | - | - | - | - |
Inter-Segment Transactions Inter-Segment Transactions Growth | -214.59 | -224.63 | -264.13 | -235.13 | -215.69 | -207.09 |
Marketing Marketing Growth | 474.29 | 473.89 | 427.53 | 420.23 | 414.15 | 383.98 |
Total Total Growth | 773.05 | 743.48 | 763.75 | 829.51 | 817.7 | 648.68 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 128.07 | 97.98 | 27.41 | 25.32 | 124.95 | 99.04 |
Total Debt Total Debt Growth | 107.69 | 121.82 | 114.41 | 65.43 | 72.17 | 0.71 |
Net Cash (Debt) Net Cash Growth | 20.38 | -23.85 | -87 | -40.11 | 52.78 | 98.32 |
Net Cash Growth | - | - | - | - | -46.32% | - |
Net Cash Per Share Net Cash Per Share Growth | 0.40 | -0.47 | -1.70 | -0.75 | 0.99 | 1.77 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 167.64 | 44.52 | 51.67 | 54.2 | 237.6 | 149.44 |
Capital Expenditures CapEx Growth | -45.87 | -8.16 | -3.39 | -5.5 | -50.72 | -40.22 |
Free Cash Flow Free Cash Flow Growth | 121.77 | 36.36 | 48.28 | 48.7 | 186.88 | 109.22 |
Free Cash Flow Growth | 326.94% | -24.69% | -0.87% | -73.94% | 71.10% | 1348.77% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 79.63% | 64.83% | 62.55% | 58.88% | 63.20% | 59.32% |
Operating Margin | 17.44% | 25.00% | 23.49% | 26.54% | 31.29% | 27.99% |
Pretax Margin | 30.43% | 24.65% | 23.27% | 26.57% | 31.55% | 28.15% |
Profit Margin | 23.94% | 18.88% | 17.92% | 20.53% | 24.42% | 23.60% |
FCF Margin | 15.75% | 4.89% | 6.32% | 5.87% | 22.85% | 16.84% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.959 | 0.959 | 0.935 | 1.104 | 1.294 | 0.956 |
Dividend Per Share Growth | 2.60% | 2.60% | -15.28% | -14.69% | 35.39% | 150.68% |
Dividend Yield | 1.64% | 2.95% | 3.50% | 4.31% | 2.65% | 0.52% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 16.18 | 23.09 | 23.58 | 18.81 | 9.67 | 26.74 |
Forward PE | 20.05 | 21.58 | 19.02 | 19.76 | 12.76 | 25.70 |
P/FCF Ratio | 16.71 | 89.33 | 66.69 | 64.05 | 10.30 | 37.46 |
PS Ratio | 3.88 | 4.37 | 4.22 | 3.76 | 2.35 | 6.31 |